Patients reporting peptide harms say MAHA medical-freedom push overlooks them

The wire

1. 01The Buffalo News reports on patients who say peptide products harmed them and whose accounts have gained little traction amid the medical-freedom campaign around peptide access.
2. 02Clinicians and compounders weighing expanded peptide offerings face adverse-event narratives that are largely absent from the current policy debate.
3. 03Individual patient accounts are not controlled safety data, and the article does not establish causation for the reported harms.

From the source

They say these peptides hurt them. Their stories are lost in MAHA’s push for medical freedom.